Eagle Pharmaceuticals Inc (EGRX) - Thursday, Jul 25, 2024
Eagle Pharmaceuticals is facing financial difficulties, including delayed filings, management changes, and potential delisting from the NASDAQ
136 Views
Endo International (ENDP US): Still in Troubled Waters; No Near-Term Growth Driver Is Seen
Weak Q1 performance, top-selling drug facing generic competition, high debt burden, and ongoing opioid litigations remain major overhangs. Shares...
326 Views
Para IV Winners & Losers - May 2018
This month’s Para IV developments suggest that there is likely to be benefit to Amneal Pharmaceuticals Inc (AMRX US) on Lialda, BioQ pharma for...
125 Views
No more insights